We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SBRY:LSEJ Sainsbury plc Analysis

Data as of 2026-03-11 - not real-time

£336.20

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

J Sainsbury’s share price of £3.36 sits just above the identified support level of £3.30 and remains above the 50‑day SMA (≈£3.33) while trailing the 20‑day SMA (≈£3.49), indicating a modest bullish bias despite a bearish MACD histogram and a neutral RSI of 42. Increasing volume and a 30‑day volatility of 17.6% suggest active trading and heightened price swings. The company’s revenue grew 2.8% YoY to £33.3 bn, yet thin margins (gross 7%, operating 2.9%, net 1%) and a debt‑to‑equity ratio above 100% highlight financial pressure, though operating cash flow of £1.21 bn supports a 4.12% dividend yield with a 74% payout ratio. A DCF‑derived fair value of £0.24 per share starkly contrasts with the market price, but analysts’ revised price targets around £3.47 imply only a modest upside of ~3.6%. Recent material news – a £458 k share buy‑back, ongoing Argos turnaround efforts, and exploratory talks with JD.com – provide catalysts that could bolster earnings and justify the current valuation. Overall, the stock trades in a defensive grocery sector with strong cash flow, yet the high leverage and low growth temper enthusiasm.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support with bullish trend but bearish MACD
  • Strong dividend yield offering immediate income
  • Pending outcomes of Argos restructuring and JD.com discussions

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Modest upside indicated by analyst price targets and share repurchase
  • Potential revenue uplift from Argos improvements and e‑commerce partnership
  • Defensive sector positioning supporting stable cash flows

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Low growth and high leverage constrain long‑term capital appreciation
  • Sustainable dividend stream offsets growth concerns
  • Consumer‑defensive nature provides resilience through economic cycles

Key Metrics & Analysis

Financial Health

Revenue Growth2.80%
Profit Margin0.99%
P/E Ratio18.7
ROE6.61%
ROA3.08%
Debt/Equity102.27
P/B Ratio120.5
Op. Cash Flow£1.2B
Free Cash Flow£393.4M

Technical Analysis

TrendBullish
RSI42.3
Support£330.00
Resistance£361.80
MA 20£349.10
MA 50£333.45
MA 200£316.85
MACDBearish
VolumeIncreasing
Fear & Greed Index77.38

Valuation

Fair Value£23.73
Target Price£348.23
Upside/Downside3.58%
GradeFair
TypeBlend
Dividend Yield4.12%

Risk Assessment

Beta-0.22
Volatility17.62%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.